Skip to main content
. 2009 Dec 14;1(2):e2009019. doi: 10.4084/MJHID.2009.019

Table 4.

Characteristics of patients with PTLD

Patients with PTLD 6

Patients with EBV + PCR 5/6 (83.3%)

Patients with histological diagnosis of PTLD 2/6 (33.3%)

Donor 6 MUD

Stem Cell Source 5/6 (83.3%) PB
1/6 (16.6%) CB

Conditioning Regimen (abl/RIC) 4/2

GVHD prophylaxis 5/6 (83.3%) ATG
1/6 (16.6%) Campath-1H

Presence of □-peak 6/6

Presence of Monoclonal Gammopathy 5/6 (83.3%)
IgGk 2/5 (40%)
IgGλ 1/5 (20%)
IgAk 1/5 (20%)
IgMk+IgGλ 1/5 (20%)

GvHD (acute vs chronic) 2 vs 1